A1 Refereed original research article in a scientific journal

Extended safety profile of oral clodronate after long-term use in primary breast cancer patients



Authors: Atula S, Powles T, Paterson A, McCloskey E, Nevalainen J, Kanis J

Publisher: ADIS INTERNATIONAL LTD

Publication year: 2003

Journal:: Drug Safety

Journal name in source: DRUG SAFETY

Journal acronym: DRUG SAFETY

Volume: 26

Issue: 9

First page : 661

Last page: 671

Number of pages: 11

ISSN: 0114-5916

DOI: https://doi.org/10.2165/00002018-200326090-00005


Abstract
Conclusion: These results indicate that in women with early breast cancer receiving adjuvant systemic therapy, oral clodronate for 2 years is generally well tolerated with no serious long-term sequelae, providing a safe, long-term therapy in the adjuvant setting.



Last updated on 2025-14-10 at 09:40